rs3212369

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002386.4(MC1R):​c.*140A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 756,892 control chromosomes in the GnomAD database, including 13,290 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4352 hom., cov: 32)
Exomes 𝑓: 0.16 ( 8938 hom. )

Consequence

MC1R
NM_002386.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.774

Publications

13 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 16-89920352-A-G is Benign according to our data. Variant chr16-89920352-A-G is described in ClinVar as [Benign]. Clinvar id is 321444.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MC1RNM_002386.4 linkc.*140A>G 3_prime_UTR_variant Exon 1 of 1 ENST00000555147.2 NP_002377.4 Q01726Q1JUL4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555147.2 linkc.*140A>G 3_prime_UTR_variant Exon 1 of 1 6 NM_002386.4 ENSP00000451605.1 Q01726
ENSG00000198211ENST00000556922.1 linkc.950+144A>G intron_variant Intron 1 of 4 2 ENSP00000451560.1 A0A0B4J269

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33349
AN:
152006
Hom.:
4344
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.365
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.154
Gnomad EAS
AF:
0.268
Gnomad SAS
AF:
0.125
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.170
Gnomad OTH
AF:
0.213
GnomAD4 exome
AF:
0.163
AC:
98548
AN:
604768
Hom.:
8938
Cov.:
7
AF XY:
0.161
AC XY:
50284
AN XY:
312582
show subpopulations
African (AFR)
AF:
0.364
AC:
5490
AN:
15092
American (AMR)
AF:
0.128
AC:
3006
AN:
23574
Ashkenazi Jewish (ASJ)
AF:
0.154
AC:
2369
AN:
15432
East Asian (EAS)
AF:
0.172
AC:
5479
AN:
31922
South Asian (SAS)
AF:
0.117
AC:
5842
AN:
50136
European-Finnish (FIN)
AF:
0.106
AC:
4766
AN:
44754
Middle Eastern (MID)
AF:
0.252
AC:
932
AN:
3692
European-Non Finnish (NFE)
AF:
0.166
AC:
64694
AN:
389186
Other (OTH)
AF:
0.193
AC:
5970
AN:
30980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4992
9983
14975
19966
24958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1132
2264
3396
4528
5660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.219
AC:
33377
AN:
152124
Hom.:
4352
Cov.:
32
AF XY:
0.211
AC XY:
15679
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.365
AC:
15112
AN:
41458
American (AMR)
AF:
0.158
AC:
2417
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.154
AC:
535
AN:
3470
East Asian (EAS)
AF:
0.269
AC:
1390
AN:
5160
South Asian (SAS)
AF:
0.126
AC:
610
AN:
4828
European-Finnish (FIN)
AF:
0.104
AC:
1104
AN:
10596
Middle Eastern (MID)
AF:
0.282
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
0.170
AC:
11574
AN:
67996
Other (OTH)
AF:
0.212
AC:
447
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1277
2555
3832
5110
6387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.201
Hom.:
2164
Bravo
AF:
0.231
Asia WGS
AF:
0.214
AC:
746
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.1
DANN
Benign
0.57
PhyloP100
0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212369; hg19: chr16-89986760; COSMIC: COSV59624658; COSMIC: COSV59624658; API